RT @drdavidliew: Ultrasound and MRI have taught us a lot about PMR, but it's the power of PET/CT which illustrated the s

Tweet Author

Tweet Content

Ultrasound and MRI have taught us a lot about PMR, but it's the power of PET/CT which illustrated the specific pathology of PMR in full color vision. @drceowen #ACR22 @RheumNow https://t.co/N8hVjqpVwe

RT @ericdeinmd: 14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 ð¦´ð¦´ Initial Fracture R

Tweet Author

ericdeinmd

Tweet Content

14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 🦴🦴 Initial Fracture Risk Assessment - by age - remember: no FRAX scores <40 yo Fracture re-assessments every 1-2 years with repeat BMD and risk stratifications @RheumNow https://t.co/QlCVM1lDb0

RT @AurelieRheumo: BE OPTIMAL: BKZ in PsA Phase 3 RCT Data at 52 wks 700+ completed study ACR50: 53% PBO/BKZ, 54% BKZ,

Tweet Author

AurelieRheumo

Tweet Content

BE OPTIMAL: BKZ in PsA Phase 3 RCT Data at 52 wks 700+ completed study ACR50: 53% PBO/BKZ, 54% BKZ, 50% ADA PASI 100 65% PBO/BKZ, 61% BKZ, 48% ADA No Rx progression 87% PBO/BKZ, 89% BKZ, 94% ADA Candida infections 7% BKZ, 0.7% ADA https://t.co/MMjN1Aa3qf Abs#L02 #ACR22 @Rheumnow https://t.co/keF0QOZMwA

Links

Bimekizumab Treatment in Biologic DMARD-Naïve Patients with Active Psoriatic Ar… http://bit.ly/3O4C0cK

RT @KDAO2011: Dr. B Humphrey #ACR22 #Osteoporosis Guidelines: in patients under 40 yo, you cannot calculate #FRAX score,

Tweet Author

KDAO2011

Tweet Content

Dr. B Humphrey #ACR22 #Osteoporosis Guidelines: in patients under 40 yo, you cannot calculate #FRAX score, assess BMD and in children get also thoracolumbar xrays. Get repeat testing every 1-2 years #ACR22 @rheumnow https://t.co/CgsvzGKYuV

RT @Janetbirdope: Get the skinny on Bimmy! Gotta learn this name #Bimekizumab in bio naive PsA N=852 Bimmy=IL17 A &

Tweet Author

Janetbirdope

Tweet Content

Get the skinny on Bimmy! Gotta learn this name #Bimekizumab in bio naive PsA N=852 Bimmy=IL17 A & F inhibitor Great data on skin & joints. Where will it fit in as we have other IL17Ai’s is IL17F giving added value? #ACR22 #ACRBest @RheumNow https://t.co/wNAzTaLhsM

RT @AurelieRheumo: 800+ women w/ IMID & 1700+ ctrl w/ 6 yrs follow-up All GC users < BMD levels -4.2% > 2.5mg/

Tweet Author

AurelieRheumo

Tweet Content

800+ women w/ IMID & 1700+ ctrl w/ 6 yrs follow-up All GC users < BMD levels -4.2% > 2.5mg/d -2.7% <2.5mg/d Crude FX rate 4.8/100PY GC >= 5mg/d, 2.5/100PY GC < 2.5mg/d 🦴Fx incidence > IMID vs. Ctrls GC use >= 5mg/d x2 risk of Fx https://t.co/6sj77PwyYQ Abs#L01 #ACR22 @Rheumnow https://t.co/OZhfuh0Jrm

Links

Impact of Glucocorticoid Dosing and Anti-Osteoporotic Treatment on Bone Health … http://bit.ly/3Ac05sn

14 November 2022

Do different genders experience PsA differently?

There has been a lot of talk lately about the difference in the way male and female PsA patients experience their disease. Are the differences only cultural or are there important clinical differences in the disease presentation, organ involvement and complications that physicians should be aware of?

RT @ericdeinmd: 14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 ð¦´ð¦´ Reminder: Recalcul

Tweet Author

ericdeinmd

Tweet Content

14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 🦴🦴 Reminder: Recalculate FRAX scores with scaling for prednisone equivalent dosing! Use other clinical fracture risk assessments @RheumNow https://t.co/qZDlb1Cij7

RT @KDAO2011: Dr. B Humphrey #ACR22 #Osteoporosis Guidelines: FRAX needs to be adjusted according to the dose of GC's (7

Tweet Author

KDAO2011

Tweet Content

Dr. B Humphrey #ACR22 #Osteoporosis Guidelines: FRAX needs to be adjusted according to the dose of GC's (7.5+ mg/day multiply FRAX score by 1.2) #ACR22 @rheumnow https://t.co/U7IOjbTwxN

RT @DrPetryna: #L01 #acr22 @rheumnow chronic GC use in rheum Dx assoctd w/â¬ï¸ T scores & â¬ï¸fracture even if d

Tweet Author

DrPetryna

Tweet Content

#L01 #acr22 @rheumnow chronic GC use in rheum Dx assoctd w/⬇️ T scores & ⬆️fracture even if dose 2.5 mg or less. GC use ≥5 mg/day associated w/ 2-fold higher risk of fracture of any kind compared to all other doses& controls (aHR 2.37, 95% CI 1.33-4.23).Preventable w/anti-OP Rx https://t.co/sCWkEBPMMT

Topics

RT @drdavidliew: Ultrasound and MRI have taught us a lot about PMR, but it's the power of PET/CT which illustrated the s

RT @ericdeinmd: 14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 ð¦´ð¦´ Initial Fracture R

RT @AurelieRheumo: BE OPTIMAL: BKZ in PsA Phase 3 RCT Data at 52 wks 700+ completed study ACR50: 53% PBO/BKZ, 54% BKZ,

RT @KDAO2011: Dr. B Humphrey #ACR22 #Osteoporosis Guidelines: in patients under 40 yo, you cannot calculate #FRAX score,

RT @Janetbirdope: Get the skinny on Bimmy! Gotta learn this name #Bimekizumab in bio naive PsA N=852 Bimmy=IL17 A &

RT @AurelieRheumo: 800+ women w/ IMID & 1700+ ctrl w/ 6 yrs follow-up All GC users < BMD levels -4.2% > 2.5mg/

RT @ericdeinmd: 14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 ð¦´ð¦´ Reminder: Recalcul

RT @KDAO2011: Dr. B Humphrey #ACR22 #Osteoporosis Guidelines: FRAX needs to be adjusted according to the dose of GC's (7

RT @DrPetryna: #L01 #acr22 @rheumnow chronic GC use in rheum Dx assoctd w/â¬ï¸ T scores & â¬ï¸fracture even if d

Do you get our email newsletter?

RT @drdavidliew: Ultrasound and MRI have taught us a lot about PMR, but it's the power of PET/CT which illustrated the s

RT @ericdeinmd: 14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 ð¦´ð¦´ Initial Fracture R

RT @AurelieRheumo: BE OPTIMAL: BKZ in PsA Phase 3 RCT Data at 52 wks 700+ completed study ACR50: 53% PBO/BKZ, 54% BKZ,

RT @KDAO2011: Dr. B Humphrey #ACR22 #Osteoporosis Guidelines: in patients under 40 yo, you cannot calculate #FRAX score,

RT @Janetbirdope: Get the skinny on Bimmy! Gotta learn this name #Bimekizumab in bio naive PsA N=852 Bimmy=IL17 A &amp;

RT @AurelieRheumo: 800+ women w/ IMID &amp; 1700+ ctrl w/ 6 yrs follow-up All GC users &lt; BMD levels -4.2% &gt; 2.5mg/

RT @ericdeinmd: 14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 ð¦´ð¦´ Reminder: Recalcul

RT @KDAO2011: Dr. B Humphrey #ACR22 #Osteoporosis Guidelines: FRAX needs to be adjusted according to the dose of GC's (7

RT @DrPetryna: #L01 #acr22 @rheumnow chronic GC use in rheum Dx assoctd w/â¬ï¸ T scores &amp; â¬ï¸fracture even if d

RT @ericdeinmd: 14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 ð¦´ð¦´ Initial Fracture R

RT @Janetbirdope: Get the skinny on Bimmy! Gotta learn this name #Bimekizumab in bio naive PsA N=852 Bimmy=IL17 A &

RT @AurelieRheumo: 800+ women w/ IMID & 1700+ ctrl w/ 6 yrs follow-up All GC users < BMD levels -4.2% > 2.5mg/

RT @ericdeinmd: 14M111 Updated ACR Guidelines for Glucocorticoid-Induced Osteoporosis #ACR22 ð¦´ð¦´ Reminder: Recalcul

RT @DrPetryna: #L01 #acr22 @rheumnow chronic GC use in rheum Dx assoctd w/â¬ï¸ T scores & â¬ï¸fracture even if d